This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: The University of Texas System, Wake Forest University. Active years: 2017-2026.
Company Filing History:
Years Active: 2017-2026
Title: Innovations in Anti-Cancer Compounds by Hui-Kuan Lin
Introduction
Hui-Kuan Lin is an accomplished inventor based in Winston-Salem, NC (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of anti-cancer compounds. His work focuses on methods and compositions that target diseases such as cancer, showcasing his commitment to advancing medical science.
Latest Patents
Hui-Kuan Lin holds a patent for anti-cancer compounds. This patent provides methods and compositions for the treatment of diseases, particularly cancer. The compounds he has developed can inhibit Skp2, and specifically, chromenone derivatives are disclosed that have the capability of reducing differentiation of pluripotent, multipotent, or totipotent cells. This innovation has therapeutic utility in treating proliferative diseases such as cancer.
Career Highlights
Hui-Kuan Lin is affiliated with the University of Texas System, where he continues to engage in groundbreaking research. His dedication to the field of cancer treatment is evident in his innovative approaches and the impact of his work on medical science.
Collaborations
Hui-Kuan Lin has collaborated with notable colleagues, including Shuxing Zhang and Chia-Hsin Chan, who contribute to his research efforts. Their combined expertise enhances the potential for significant advancements in cancer treatment.
Conclusion
Hui-Kuan Lin's contributions to the development of anti-cancer compounds highlight his role as a leading inventor in the medical field. His innovative work continues to pave the way for new therapeutic options in the fight against cancer.